Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants

Overview of attention for article published in Frontiers in Medicine, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 10 X users
patent: 2 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

USE OF CALCINEURIN INHIBITOR FREE CTLA4-IG + ANTI-IL6/IL6R FOR LONG TERM…

Application EP-4025596-A4

European Patent Office

METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS

Grant EP-3920970-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.